This webinar will discuss the final guidance of the same name published in July of this year. The webinar will be held November 12, 2024 @ 11:00 AM - 12:00 PM ET
Some of the content will cover:
"Our FDA subject matter experts will also address recommendations from the guidance including, deciding whether and when to conduct the study, as well as how to design and report results from a human radiolabeled mass balance study. The presenters will communicate when and how to perform these studies, as well as how the results from the mass balance studies can inform the drug development program and consequently inform the safe and effective use of drugs."
#fda #massbalance
More details and how to register are available here:
Radiolabeled Mass Balance Studies
| U.S. Food and Drug Administration |
remove preview |
|
|
------------------------------
Mark Arnold Ph.D., FAAPS
Westampton, NJ
[email protected]Bioanalytical Solution Integration
LinkedIn:
https://www.linkedin.com/in/markearnoldphd/Website & Blog: Bioanalysis & Biomarkers <bioanalysisandbiomarkers.blogspot.com>
------------------------------
</bioanalysisandbiomarkers.blogspot.com>